Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study

[1] Møller P(2017)Cancer incidence and survival in lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective lynch syndrome database Gut. 66 464-472

[2] Seppälä T(2020)The prospective lynch syndrome database reports enable evidence-based personal precision health care Hered Cancer Clin Pract. 18 6-2000

[3] Bernstein I(2006)Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without lynch syndrome Gastroenterology. 130 1995-444

[4] Holinski-Feder E(2020)Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer genetics group (UKCGG) Gut. 69 411-1664

[5] Sala P(2017)Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective lynch syndrome database Gut. 66 1657-9.e2

[6] Evans DG(2019)Lack of association between screening interval and cancer stage in lynch syndrome may be accounted for by over-diagnosis; a prospective lynch syndrome database report Hered Cancer Clin Pract 17 8-402

[7] Møller P(2018)No difference in colorectal Cancer incidence or stage at detection by colonoscopy among 3 countries with different lynch syndrome surveillance policies Gastroenterology. 155 1400-A1A9

[8] Dove-Edwin I(2019)Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer BJS Open 3 395-213

[9] de Jong AE(2017)PWE-027 An interim analysis of the ‘getting fit’ project in Nottingham: integrating faecal immunochemical testing in a two week wait pathway Gut. 66 A138-944

[10] Adams J(2017)Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework BMC Health Serv Res 17 88-85

[1] Møller P(2017)Cancer incidence and survival in lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective lynch syndrome database Gut. 66 464-472

[2] Seppälä T(2020)The prospective lynch syndrome database reports enable evidence-based personal precision health care Hered Cancer Clin Pract. 18 6-2000

[3] Bernstein I(2006)Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without lynch syndrome Gastroenterology. 130 1995-444

[4] Holinski-Feder E(2020)Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer genetics group (UKCGG) Gut. 69 411-1664

[5] Sala P(2017)Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective lynch syndrome database Gut. 66 1657-9.e2

[6] Evans DG(2019)Lack of association between screening interval and cancer stage in lynch syndrome may be accounted for by over-diagnosis; a prospective lynch syndrome database report Hered Cancer Clin Pract 17 8-402

[7] Møller P(2018)No difference in colorectal Cancer incidence or stage at detection by colonoscopy among 3 countries with different lynch syndrome surveillance policies Gastroenterology. 155 1400-A1A9

[8] Dove-Edwin I(2019)Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer BJS Open 3 395-213

[9] de Jong AE(2017)PWE-027 An interim analysis of the ‘getting fit’ project in Nottingham: integrating faecal immunochemical testing in a two week wait pathway Gut. 66 A138-944

[10] Adams J(2017)Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework BMC Health Serv Res 17 88-85